Swedish biotech companies have a broad and varied product pipeline that is attracting attention from venture capitalists and pharmaceutical companies.
|Articles|July 1, 2002
- Pharmaceutical Technology-07-02-2002
- Volume 26
- Issue 7
How to Engage in a Strategic Outsourcing Relationship
Author(s)Les Blumberg
Carefully crafted outsourcing arrangements allow companies to become powerful partners in the quest for market share.
Advertisement
Articles in this issue
about 24 years ago
Congress Adopts New User Fee Programabout 24 years ago
Validation Basics: A System Developer's Approach to Validationabout 24 years ago
Particle-Size Distribution II: The Problem of Sampling Powdered Solidsabout 24 years ago
Novel Approaches for Topical Delivery of Acetazolamideabout 24 years ago
Outsourcing Outlookabout 24 years ago
Electrodeionization in Pharmaceutical Water TreatmentAdvertisement
Related to this article
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Shilpa Pharma Lifesciences Limited will launch a new small-molecule CDMO at CPHI Milan in October.
This article explains the 4 shifts enabling faster, lower-risk, commercially successful biologics technology transfer.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Fundamentals: Digital Pathology in Drug Development, Part 1
2
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
3
PharmTech’s Weekly Roundup—September 25, 2026
4
Weekly Basal Insulin Efsitora: A New Biologics CMC Benchmark
5